The DIAPH3 Knockout SK-HEP-1 Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal population derived from the SK-HEP-1 human hepatic adenocarcinoma cell line, featuring targeted disruption of the DIAPH3 gene. This loss-of-function model enables systematic investigation of DIAPH3-mediated actin dynamics and associated cellular processes in a liver cancer context. The polyclonal format captures a spectrum of gene-edited alleles while ensuring robust functional knockout at the population level, minimizing clonal selection artifacts and offering a versatile resource for pooled biochemical and cell-based assays.
SK-HEP-1 is a widely employed human hepatic adenocarcinoma cell line originally isolated from the ascitic fluid of a liver adenocarcinoma patient. It displays adherent epithelial morphology and retains key features of high?grade liver cancer, including metastatic propensity and drug resistance. The cell line has been extensively characterized in studies of hepatocellular carcinoma progression, chemosensitivity testing??particularly with sorafenib??and intracellular signaling pathways, providing a biologically relevant host background for knockout models.
DIAPH3 encodes a formin?family actin nucleation and elongation factor that operates as a critical effector of Rho GTPases, including RhoA, Rac1, and Cdc42. Upon activation by upstream RhoGEFs or mechanical stress, DIAPH3 promotes actin polymerization through its interaction with profilin?Cactin complexes, thereby driving cytoskeletal remodeling. This activity modulates focal adhesion turnover by regulating components such as vinculin and paxillin and influences transcriptional programs via the SRF?CMAL/MRTF axis. DIAPH3 also forms complexes with IQGAP1 and the APC protein, integrating signals that orchestrate cell migration, adhesion, and cytokinesis. Aberrant DIAPH3 function has been implicated in autosomal dominant nonsyndromic hearing loss (DFNA1) and in the progression of multiple cancers.
In the SK-HEP-1 hepatic adenocarcinoma context, DIAPH3 knockout provides a powerful tool to dissect the gene??s contributions to liver cancer aggressiveness. Given the cell line??s intrinsic metastatic behavior and its frequent use in hepatocellular carcinoma research, this model is especially suited for studying DIAPH3-dependent mechanisms of tumor cell migration, invasion, and focal adhesion dynamics. Moreover, because SK-HEP-1 cells are utilized in drug sensitivity assays??including sorafenib??the knockout population allows for direct interrogation of DIAPH3??s impact on chemoresistance. These studies can reveal how DIAPH3-mediated actin cytoskeletal regulation intersects with oncogenic signaling to influence malignant phenotypes.
Typical research applications encompass knockout validation via Western blotting and RT?qPCR, Transwell migration and invasion assays, and F?actin staining followed by confocal microscopy to visualize actin network alterations. Co?immunoprecipitation can be employed to assess disrupted interactions between DIAPH3 and actin or profilin, while sorafenib dose?response curves may uncover DIAPH3?dependent resistance mechanisms. The polyclonal population is also amenable to high?content imaging, interactor proteomics, and screening campaigns. For additional information, please contact Ascent Research.
